Session Datesort descending
Hematologic Malignancy Grand Rounds - FY18 Advances in Umbilical Cord Blood Transplantation 02/02/2018 - 9:00am to 10:00am EST
Hematologic Malignancy Grand Rounds - FY18 Relapse following allogeneic HSCT: Should I use a donor lymphocyte infusion (DLI) or a checkpoint inhibitor antibody 02/09/2018 - 9:00am to 10:00am EST
Hematologic Malignancy Grand Rounds - FY18 The LAST Study: Life After Stopping TKI’s 02/16/2018 - 9:00am to 10:00am EST
Hematologic Malignancy Grand Rounds - FY18 The Curious Case of the Vanishing Neoplasm 02/23/2018 - 9:00am to 10:00am EST
Hematologic Malignancy Grand Rounds Extramedullary Disease in AML Does it Matter 03/02/2018 - 9:00am to 10:00am EST
Hematologic Malignancy Grand Rounds - FY18 Genomic diagnosis and treatment of lymphomas: From single cells to many humans 03/09/2018 - 9:00am to 10:00am EST
Hematologic Malignancy Grand Rounds - FY18 The Dilemma of CTCL 03/16/2018 - 9:00am to 10:00am EDT
Hematologic Malignancy Grand Rounds - FY18 Microparticles and Cancer 03/23/2018 - 9:00am to 10:00am EDT
Hematologic Malignancy Grand Rounds - FY18 When standard treatment for rare disease fails- what next 03/30/2018 - 9:00am to 10:00am EDT
Hematologic Malignancy Grand Rounds - FY18 9100 Questions: The True Value of Yellow Gowns? Miracle or Myth: Claritin and Neulasta 04/06/2018 - 9:00am to 10:00am EDT

Pages